Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,615 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design and rationale of low-dose erythropoietin in patients with ST-segment elevation myocardial infarction (EPO-AMI-II study): a randomized controlled clinical trial.
Minamino T, Toba K, Higo S, Nakatani D, Hikoso S, Umegaki M, Yamamoto K, Sawa Y, Aizawa Y, Komuro I; EPO-AMI-II study investigators. Minamino T, et al. Among authors: yamamoto k. Cardiovasc Drugs Ther. 2012 Oct;26(5):409-16. doi: 10.1007/s10557-012-6410-4. Cardiovasc Drugs Ther. 2012. PMID: 22940818 Clinical Trial.
Mitral Valve Structure in Addition to Myocardial Viability Determines the Outcome of Functional Mitral Regurgitation After Coronary Artery Bypass Grafting.
Yoshida S, Fukushima S, Miyagawa S, Nakamura T, Yoshikawa Y, Hata H, Saito S, Yoshioka D, Domae K, Kashiyama N, Yamamoto K, Shintani A, Nakatani S, Toda K, Sawa Y. Yoshida S, et al. Among authors: yamamoto k. Circ J. 2017 Oct 25;81(11):1620-1627. doi: 10.1253/circj.CJ-16-1280. Epub 2017 Jun 16. Circ J. 2017. PMID: 28626146 Free article.
Low-Dose Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction (EPO-AMI-II)　- A Randomized Controlled Clinical Trial.
Minamino T, Higo S, Araki R, Hikoso S, Nakatani D, Suzuki H, Yamada T, Okutsu M, Yamamoto K, Fujio Y, Ishida Y, Ozawa T, Kato K, Toba K, Aizawa Y, Komuro I; EPO-AMI-II Investigators. Minamino T, et al. Among authors: yamamoto k. Circ J. 2018 Mar 23;82(4):1083-1091. doi: 10.1253/circj.CJ-17-0889. Epub 2018 Feb 2. Circ J. 2018. PMID: 29398672 Free article. Clinical Trial.
First-in-human randomised trial and follow-up study of Plasmodium falciparum blood-stage malaria vaccine BK-SE36 with CpG-ODN(K3).
Ezoe S, Palacpac NMQ, Tetsutani K, Yamamoto K, Okada K, Taira M, Nishida S, Hirata H, Ogata A, Yamada T, Yagi M, Edula JR, Oishi Y, Tougan T, Ishii KJ, Myoui A, Horii T. Ezoe S, et al. Among authors: yamamoto k. Vaccine. 2020 Oct 27;38(46):7246-7257. doi: 10.1016/j.vaccine.2020.09.056. Epub 2020 Oct 2. Vaccine. 2020. PMID: 33012605 Clinical Trial.
A Phase II Placebo-Controlled Study of the Effect and Safety of Nanvuranlat in Patients with Advanced Biliary Tract Cancers Previously Treated by Systemic Chemotherapy.
Furuse J, Ikeda M, Ueno M, Furukawa M, Morizane C, Takehara T, Nishina T, Todaka A, Okano N, Hara K, Nakai Y, Ohkawa K, Sasaki T, Sugimori K, Yokoyama N, Yamamoto K. Furuse J, et al. Among authors: yamamoto k. Clin Cancer Res. 2024 Sep 13;30(18):3990-3995. doi: 10.1158/1078-0432.CCR-24-0461. Clin Cancer Res. 2024. PMID: 39058429 Clinical Trial.
A prospective multicenter observational study evaluating the risk of periendoscopic events in patients using anticoagulants: the Osaka GIANT Study.
Inoue T, Iijima H, Yamada T, Okuyama Y, Takahashi K, Nishida T, Ishihara R, Akasaka T, Kobayashi I, Kuroshima T, Yasunaga Y, Yamamoto K, Nakahara M, Doi Y, Nakajima S, Mukai A, Masuda E, Yoshii S, Hayashi Y, Minamiguchi H, Sakata Y, Yamamoto K, Tsujii M, Takehara T. Inoue T, et al. Among authors: yamamoto k. Endosc Int Open. 2019 Feb;7(2):E104-E114. doi: 10.1055/a-0754-1997. Epub 2019 Jan 17. Endosc Int Open. 2019. PMID: 30705940 Free PMC article.
15,615 results
You have reached the last available page of results. Please see the User Guide for more information.